Effects of atomoxetine and osmotic release oral system-methylphenidate on executive functions in patients with combined type attention-deficit/hyperactivity disorder

B Ince Tasdelen, E Karakaya… - Journal of child and …, 2015 - liebertpub.com
… , comparative data are limited regarding executive functions. In the present study, we aimed
to evaluate and compare the effects on executive functions, activity, treatment response time, …

Effect of osmoticrelease oral system methylphenidate on different domains of attention and executive functioning in children with attention‐deficit–hyperactivity …

NJ Blum, AF Jawad, AT Clarke… - … Medicine & Child …, 2011 - Wiley Online Library
executive functioning so that there would be at least two tests assessing each domain. We
identified the domain of attention or executive functioning … Some tests measure functioning in …

Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study

KS Na, SI Lee, SD Hong, JH Kim, SH Shim… - International clinical …, 2013 - journals.lww.com
… Learning skills and executive function tests were measured at baseline and week 12.
Executive function tests were carried out by experienced clinical child and adolescent …

Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in …

Y Taş Torun, Y Işik Taner, E Güney… - Applied …, 2022 - Taylor & Francis
… The aim of this study to compare the clinic efficacy and effects of osmotic release oral
system-methylphenidate and atomoxetine on executive function in children and adolescents with …

An open-label, self-control, prospective study on cognitive function, academic performance, and tolerability of osmotic-release oral system methylphenidate in children …

Y Zheng, JM Liang, HY Gao, ZW Yang, FJ Jia… - Chinese Medical …, 2015 - mednexus.org
… [8,10,11,12] Once-daily osmotic-release oral system (OROS)-MPH is a long-acting … -release
methylphenidate (IR-MPH).[11] The OROS-MPH treatment improved executive functions of …

… of attention and inhibition in the late afternoon in children with attention-deficit hyperactivity disorder (ADHD) treated with osmotic-release oral system methylphenidate

H Slama, P Fery, D Verheulpen… - Journal of Child …, 2015 - journals.sagepub.com
… Among the procedures used to assess executive functions, the Stroop task 50 that measures
conflict resolution and interference inhibition remains by far the most studied. Typically, …

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

AFT Arnsten, BM Li - Biological psychiatry, 2005 - Elsevier
… effects on PFC function, whereas high concentrations of NE released during stress … infused
bilaterally and chronically for 8 days, using osmotic pumps, into the dorsolateral PFC of two …

Remission rate and functional outcomes during a 6-month treatment with osmotic-release oral-system methylphenidate in children with attention-deficit/hyperactivity …

Y Su, H Li, Y Chen, F Fang, T Xu, H Lu… - Journal of Clinical …, 2015 - journals.lww.com
… The treatment with MPH also improves executive functions (EFs) including working memory,
… as well as compared the executive and social functioning outcomes between patients who …

[HTML][HTML] Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit …

K Mizuno, T Yoneda, M Komi, T Hirai, Y Watanabe… - NeuroImage: Clinical, 2013 - Elsevier
… Research continues to suggest that osmotic release oral system-methylphenidate (OROS-MPH)
lessens ADHD symptoms throughout the day and has greater adherence, thought to be …

Memantine in the treatment of executive function deficits in adults with ADHD: A pilot-randomized double-blind controlled clinical trial

J Biederman, R Fried, L Tarko… - Journal of Attention …, 2017 - journals.sagepub.com
… Rating Inventory of Executive Functions–Adult … osmotic release oral system-methylphenidate
(OROS-MPH) was associated with improvements in selective areas of executive functioning